# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dorothea Lange (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML045-SYN
- Date: 2026-02-25
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gwendolyn Ashford-Mensah, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Results of the nerve and muscle tests; neuromuscular consultation this morning. **S**

## History of present illness

Ms. Lange returns 16 days after presenting with about 18 months of new fatigue, slowly increasing weakness of the left leg and both shoulders as well as her polio-affected right leg, aching after field work, and two falls. Her blood tests at the first visit excluded the common other causes: hemoglobin 13.1, TSH 2.1, HbA1c 5.4 percent, B12 512, creatinine 0.7, ESR 12, and CRP 0.3 were normal; creatine kinase was mildly raised at 228 and 25-hydroxyvitamin D low at 22. Her PHQ-9 was 6. Nerve conduction studies a week ago were normal, and the needle EMG showed chronic reinnervation in the right leg and, more mildly, in the left thigh and right shoulder, with no myopathy. She saw Dr. Haddad-Sorensen this morning, who confirmed post-polio syndrome. Today she had a bone density scan and spirometry. Her heartburn is much better after two weeks of omeprazole. She asked plainly whether this would keep getting worse and whether she would have to stop working in the field. **S**

| Element | Detail |
|---|---|
| Interval change | Nerve conduction normal; EMG chronic reinnervation in three limbs; no myopathy or neuropathy |
| Exclusion tests | Thyroid, blood count, glucose, B12, kidney and liver tests, ESR and CRP normal; creatine kinase mildly raised; vitamin D low |
| Diagnosis | Post-polio syndrome confirmed at the neuromuscular consultation this morning |
| Today | Bone density scan with vertebral fracture assessment; spirometry |
| Heartburn | Better after two weeks of omeprazole |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue after two hours of activity; no fever or weight loss |
| Musculoskeletal | Positive | Aching in both thighs and shoulders after work; no joint swelling |
| Neurological | Positive | Weaker left leg and shoulders; cold right foot; no numbness |
| Respiratory | Negative | No breathlessness lying flat and no morning headache |
| Ears, nose, mouth, and throat | Negative | No trouble swallowing or choking |
| Gastrointestinal | Positive | Heartburn now once or twice a week; no difficulty swallowing, vomiting, or black stools |
| Psychiatric | Positive | Discouraged by the tiredness; no thoughts of self-harm |

7 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day **S**
- Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth 30 to 60 minutes before breakfast, an eight-week trial for heartburn **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/76 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 97% on room air; weight 50.3 kg; BMI 21.8 kg/m². All vital signs are synthetic.

Intact PTH: 58 pg/mL; Alkaline phosphatase: 82 U/L; Phosphate: 3.4 mg/dL; Magnesium: 2 mg/dL; Forced vital capacity (seated): 2.52 L; Forced vital capacity, percent predicted (seated): 92%; FEV1/FVC ratio: 78%; Lumbar spine T-score (DXA): -1.8 (low); Right femoral neck T-score (DXA): -2.7 (low); Left femoral neck T-score (DXA): -1.6 (low). All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Small, alert woman; precise historian |
| Musculoskeletal | Right calf and thigh thinner than the left; high-arched right foot; right knee hyperextends in stance |
| Neurological | Strength (MRC): right hip abductors 4-/5, right quadriceps 3+/5, right ankle dorsiflexion 2/5, right plantar flexion 3/5; left quadriceps 4/5, left hip abductors 4/5; deltoids 4+/5 on both sides; reflexes absent at the right knee and ankle, present on the left; sensation normal; no fasciculations |
| Gait | Right foot drop with a steppage gait and right knee hyperextension; Timed Up and Go 14 seconds without an aid |
| Respiratory | Clear; full chest expansion; normal cough |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-polio syndrome** (G14). She meets the modified March of Dimes criteria: paralytic polio in childhood confirmed by history, examination, and EMG; partial recovery followed by five decades of stable function; gradual new weakness and fatigue for more than a year; and other causes excluded by normal nerve conduction, no myopathy on EMG, and normal thyroid, blood count, glucose, B12, and inflammatory markers. The mildly raised creatine kinase fits muscle overuse. Mild depressive symptoms are a response to the fatigue, not its cause. She was told that post-polio syndrome usually progresses slowly, that pacing, the right exercise, and an orthosis often stabilize or improve function, and that field work can continue with changes. **S**
   - Twelve weeks of supervised non-fatiguing exercise with rest days, then a home program.
   - Pacing and energy conservation for field days: a lighter camera on a harness, a seat stick, an assistant to carry the tripod, and a rest day after each field day.
   - Custom lightweight carbon-fiber right ankle-foot orthosis and a cane in the left hand.
   - Home overnight oximetry because her sleep is unrefreshing.
   - Sedation and anesthesia precautions recorded in the chart.
2. **Osteoporosis of the right hip, with vitamin D insufficiency** (M81.8). Right femoral neck T-score -2.7, left -1.6, lumbar spine -1.8; no vertebral fracture. Disuse of the polio-affected leg lowers bone density on that side, and with two falls her fracture risk is high (FRAX about 16 percent major and 4.5 percent hip). PTH, alkaline phosphatase, phosphate, magnesium, and calcium are normal; vitamin D is low. An oral bisphosphonate is not a good choice while she has reflux symptoms. **S**
   - Vitamin D3 2000 units daily now.
   - Zoledronic acid 5 mg intravenously once vitamin D is replete, at the next visit.
   - 24-hour urine calcium before the infusion.
   - Calcium from food, about 1200 mg a day.
3. **Falls** (Z91.81). Two falls from catching the right foot; foot drop and quadriceps weakness are the main causes. **S**
   - Orthosis and cane as above; gait and balance training.
   - Home changes: rails on the garden path, night lights, no loose rugs.
4. **Heartburn on an omeprazole trial** (R12). Responding after two weeks; no alarm features. **S**
   - Complete eight weeks, then stop and review.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Diagnostic criteria for post-polio syndrome | At diagnosis | Completed today | Modified March of Dimes criteria met: prior paralytic polio, partial recovery, stability for decades, new weakness and fatigue for more than a year, other causes excluded |
| Examination | Nerve conduction studies and needle EMG | At diagnosis | Up to date | A week ago: normal nerve conduction; chronic reinnervation in three limbs; no myopathy |
| Laboratory | Exclusion of other causes (thyroid, anemia, glucose, B12, kidney and liver, inflammation, creatine kinase) | At diagnosis | Up to date | At the first visit: all normal except creatine kinase 228 and vitamin D 22 |
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Baseline strength recorded; TUG 14 seconds without an aid |
| Imaging | Spirometry | Baseline, then yearly or with symptoms | Completed today | FVC 2.52 L, 92 percent of predicted; FEV1/FVC 78 percent; normal |
| Examination | Sleep-disordered breathing screen | At diagnosis and with symptoms | Ordered | Unrefreshing sleep; home overnight oximetry booked |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing or choking |
| Referral | Supervised non-fatiguing exercise (physical therapy) | At diagnosis | Ordered | Twelve weeks, starting next week |
| Referral | Orthotic assessment | At diagnosis and when gait changes | Ordered | Custom carbon-fiber right ankle-foot orthosis; cane supplied today |
| Self-management | Energy conservation and pacing | Every visit | Completed today | Field-day plan agreed with rest breaks and a rest day after each field day |
| Medication safety | Sedation and anesthesia precautions | At diagnosis, then before any procedure | Completed today | Alert added to the chart |
| Survey | Depression screen (PHQ-9) | At diagnosis, then periodically | Up to date | PHQ-9 6 at the first visit, mild; supportive care |
| Imaging | Bone density (DXA) with vertebral fracture assessment | Baseline, then every 2 years on treatment | Completed today | Right femoral neck -2.7, left -1.6, spine -1.8; no vertebral fracture |
| Laboratory | Secondary causes of osteoporosis (calcium, vitamin D, PTH, alkaline phosphatase, phosphate, magnesium, creatinine, TSH, blood count) | At diagnosis | Completed today | PTH 58, alkaline phosphatase 82, phosphate 3.4, magnesium 2.0 today; calcium, creatinine, TSH, and blood count normal at the first visit; vitamin D 22 |
| Laboratory | 24-hour urine calcium | At diagnosis | Ordered | Collection kit given, to be returned before the infusion |
| Examination | Fall-risk assessment | At diagnosis, then yearly | Completed today | Two falls; foot drop and quadriceps weakness; TUG 14 seconds |
| Medication safety | Reflux: alarm features and response to the proton pump inhibitor trial | During the 8-week trial | Completed today | Responding; no difficulty swallowing, weight loss, bleeding, or anemia |

## Goal progress

- Find the cause of the new weakness and fatigue within four weeks, with other treatable causes excluded. Outcome by 2026-02-25: Post-polio syndrome diagnosed at 16 days after the tests excluded thyroid disease, anemia, diabetes, B12 deficiency, neuropathy, and myopathy. **S**
- No falls over the next six months. In progress; target 2026-08-17. **S**
- Keep working in the field at least two days a week, with planned rests, without exhaustion the next day. In progress; target 2026-12-31. **S**
- Establish the cause of the heartburn and control it on the lowest effective therapy. In progress; target 2026-05-18. **S**
- Replete vitamin D and start fracture-protective treatment. In progress; target 2026-04-20. **S**

## Medication changes

- Started: Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once daily **S**

## Guideline basis

- EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006), European Federation of Neurological Societies
- Post-Polio Syndrome: Identifying Best Practices in Diagnosis & Care (diagnostic criteria for post-polio syndrome) (2001), March of Dimes
- American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update. Endocr Pract 2020;26(Suppl 1):1-46 (2020), American Association of Clinical Endocrinology
- World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing 2022;51(9):afac205 (2022), World Falls Guidelines Task Force (Age and Ageing)
- CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026), Aether Forge

## Follow-up

- Physical therapy from next week; orthosis fitting in four weeks; overnight oximetry in two weeks. Primary care review in eight weeks with vitamin D, calcium, and creatinine before zoledronic acid. **S**
- Next scheduled visit 2026-04-20: review after eight weeks of pacing and physical therapy; first zoledronic acid infusion; planning endoscopy after heartburn returned off omeprazole. **S**
